Latest Lead News

Reece Limited reported a 20% decline in EBIT for FY25, reflecting soft demand in both ANZ and US markets despite strategic branch expansions and acquisitions.

Reece Limited reported a modest revenue decline and a sharper drop in profits for FY25, reflecting subdued demand in key markets and ongoing investment in growth. The company declared a reduced fully franked dividend as it navigates a challenging housing environment.

Liberty Financial Group reported a 16% rise in statutory net profit after tax for FY25, alongside a 10% increase in underlying earnings, while maintaining stable loan growth and strong capital positions.

thl reports a statutory net loss for FY25, driven by impairments, while underlying profit falls 45%. The company maintains dividends and outlines strategic initiatives to restore growth and profitability.

My Foodie Box Ltd reported a net loss of $240,933 for FY25 following the divestment of its core meal kit business and is now pursuing a complex relisting on the ASX amid ongoing funding needs and going concern uncertainties.

International Equities Corporation Ltd reported a $1.249 million net loss for FY2025, reflecting ongoing challenges in its tourism segment amid a slowing economy and rising costs. The company’s property development and leasing operations also faced headwinds, leading to a decline in overall revenue and asset backing.

5E Advanced Materials has priced an $8.31 million public offering to fund its boron facility operations and development projects, reinforcing its position in specialty materials for clean energy and security.

Cannindah Resources launches a fully underwritten $4.5 million entitlement offer to fund accelerated drilling at its Mt Cannindah copper-gold deposit, aiming to expand its 14.5Mt resource and explore new Tier-1 porphyry targets.

Golden Mile Resources has raised $510,823 through a discounted private placement to fund further exploration at its Pearl Copper Project in Arizona and pursue strategic acquisitions.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Viridis Mining and Minerals has significantly expanded its Colossus Rare Earth Elements project in Brazil, securing an additional 2,503.6 hectares adjacent to its existing licenses. This move, backed by robust government support and strategic partnerships, enhances the project's scale and de-risks its pathway to production.